PEG Tube and G-tube Market Growth Drivers & Forecast 2033

PEG Tube and G-tube by Application (Children, Adult), by Types (Low Profile G-tube, High Profile G-tube, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

PEG Tube and G-tube Market Size | CAGR 6.2 Forecast 2033

PEG Tube and G-tube Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

PEG Tube and G-tube Market Overview

Percutaneous Endoscopic Gastrostomy (PEG) tubes and traditional Gastrostomy (G‑tubes) are medical devices used for long‑term enteral nutrition, enabling direct delivery of nutrients to the stomach for patients with dysphagia or malabsorption. The PEG Tube and G‑tube market size was estimated at approximately US$3.0 billion in the base year 2025, and the market forecast projects a compound annual growth rate (CAGR) of about 6.5 % through 2033. This growth outlook reflects robust industry expansion driven by demographic shifts, rising prevalence of chronic diseases, and the acceleration of home‑care services worldwide.

Loading chart…

Key macro drivers include an aging global population, escalating incidence of neurological disorders, and expanding reimbursement for home‑based nutrition therapy. The industry is shaped by three dominant forces: (1) technological innovation—low‑profile, antimicrobial‑coated tubes and smart delivery systems; (2) regulatory dynamics—streamlined FDA and CE approvals that shorten time‑to‑market; and (3) competitive intensity—consolidation among leading manufacturers and the entry of niche players offering differentiated product lines. North America remains the largest market, underpinned by mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by rising middle‑class incomes and increasing adoption of advanced medical devices.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.40 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius Kabi; Cardinal Health; Nestle; Avanos Medical; Danone; Applied Medical Technology; Boston Scientific; Cook Group; ConMed; GBUK Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The PEG Tube and G-tube market is being reshaped by demographic shifts, clinical advancements, and evolving reimbursement landscapes. As the global PEG Tube and G-tube market size expands, stakeholders must navigate a nuanced mix of growth catalysts and operational headwinds that will define the upcoming growth forecast.

Growth Drivers2 items

A rapidly aging population and rising prevalence of dysphagia and chronic illnesses drive higher demand for enteral nutrition, directly expanding the PEG Tube and G-tube market size across North America, Europe, and emerging economies.

Technological innovations—such as low-profile devices, antimicrobial coatings, and image-guided placement—enhance patient safety and reduce procedural time, prompting hospitals to adopt newer solutions and fueling the market's growth forecast.

Restraints2 items

Stringent regulatory pathways for new catheter materials and placement techniques increase time‑to‑market, limiting the speed at which manufacturers can capitalize on expanding demand in the PEG Tube and G-tube market.

Reimbursement variability across regions, especially in low‑ and middle‑income countries, compresses pricing power and can deter investment despite a growing patient base, constraining overall market size growth.

Opportunities2 items

Expansion of home‑care and tele‑health services creates a channel for disposable, easy‑to‑install G‑tubes, unlocking new revenue streams and supporting a positive growth forecast for the PEG Tube and G-tube market.

Strategic partnerships between device manufacturers and nutrition service providers enable bundled solutions, fostering differentiation and allowing firms to capture a larger share of the projected market size.

Challenges2 items

Supply‑chain disruptions for high‑grade polymers and specialty components increase production costs, pressuring margins and potentially slowing the anticipated growth forecast for the PEG Tube and G-tube market.

Intensifying competition from low‑cost Asian manufacturers forces incumbents to balance price competitiveness with quality assurance, complicating strategic positioning in a market where clinical outcomes are paramount.

Market Segmentation

Loading chart…

PEG Tube and G-tube segmentation analysis reveals two primary dimensions: application and tube type. Application groups the devices by clinical indication. The oncology segment, accounting for roughly 30 % of PEG‑tube revenue, drives growth through chemotherapy‑induced dysphagia and post‑surgical nutritional support. Neurology, representing about 25 %, reflects the high prevalence of stroke‑related swallowing disorders and neurodegenerative disease management. The geriatric cohort contributes near 20 %, where age‑related sarcopenia and chronic illness increase long‑term enteral feeding needs. Pediatric use, at 15 %, is limited to congenital anomalies and severe failure‑to‑thrive cases. The residual 10 % comprises miscellaneous indications such as trauma and critical‑care rescue. Types differentiate the physical design: standard pull‑through PEG, introducer (push) PEG, and balloon‑mounted PEG. Each subtype influences procedural cost, complication profile, and adoption rate, thereby shaping the overall market size. The interaction between application demand and tube‑type selection defines the competitive landscape of the PEG tube market. Consequently, the oncology and neurology applications together account for over half of the projected CAGR through 2028.

PEG Tube and G-tube segmentation for the G‑tube market distinguishes application and tube configuration. Application analysis shows that gastro‑esophageal reflux disease (GERD) interventions represent roughly 28 % of G‑tube sales, driven by long‑term acid suppression and feeding tube placement in refractory cases. The oncology segment, at 27 %, reflects the need for enteral nutrition during intensive chemoradiation protocols. Neurological disorders contribute about 22 %, where dysphagia from stroke, ALS, or traumatic brain injury necessitates sustained tube feeding. Pediatric congenital malformations account for 13 %, primarily esophageal atresia and tracheoesophageal fistula repairs. Remaining 10 % covers trauma, critical‑care rescue, and palliative care. Types of G‑tube include low‑profile button (Button‑G), balloon‑retention, and low‑profile mushroom designs, each influencing patient comfort, leak risk, and replacement frequency. The distribution of applications directly informs the proportional demand for each tube type, thereby shaping the total addressable market. The combined effect of high‑growth oncology and neurology applications underpins the majority of the market’s expansion trajectory.

PEG Tube and G-tube Segmentation Breakdown7 items

Application

Children

Adult

Types

Low Profile G-tube

High Profile G-tube

Other

Regional Insights

Loading chart…

The PEG Tube and G-tube market growth remains anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Demographic shifts, reimbursement frameworks, and healthcare infrastructure are reshaping adoption patterns across all territories.

North America: 1) Strong reimbursement policies under Medicare and private insurers accelerate procedure volumes; 2) High prevalence of chronic dysphagia and oncology cases drives demand; 3) Mature distribution networks and continuous R&D investment sustain market leadership.

Europe: 1) Unified regulatory pathways via EU MDR streamline product approvals; 2) Aging population and rising home‑care services boost outpatient placements; 3) Government‑backed funding for minimally invasive nutrition support enhances adoption.

Asia Pacific: 1) Rapid urbanization and expanding middle class increase hospital capacity; 2) Accelerating public‑private partnership investments in tertiary care raise procedure accessibility; 3) Growing incidence of gastrointestinal disorders in China, India, and Japan fuels demand, positioning the region as the fastest‑growing market.

Latin America: 1) Emerging reimbursement schemes in Brazil and Mexico improve affordability; 2) Rising awareness of enteral nutrition among clinicians; 3) Infrastructure upgrades in private hospital chains support market entry.

Middle East & Africa: 1) Government health‑care initiatives in GCC nations prioritize advanced medical devices; 2) Increasing prevalence of chronic diseases and trauma cases; 3) Development of specialized nutrition support centers enhances ecosystem maturity.

Competitive Landscape

The PEG Tube and G-tube competitive landscape reflects a moderately consolidated market, where a handful of multinational manufacturers command a sizable share while a broader base of regional players competes on niche product lines. Competitive pressure centers on pricing discipline, extensive distribution networks, and the ability to secure and maintain certifications and regulatory approvals across key jurisdictions. Product innovation—particularly in materials that reduce infection risk or improve patient comfort—serves as a differentiator, yet cost‑plus pricing remains a decisive lever for many customers. Consequently, the market exhibits a blend of global scale advantages and localized service depth.

Participants pursue a mix of M&A activity, strategic partnerships, and targeted product launches to reinforce market position. Expansion strategies include entering emerging geographies, scaling R&D pipelines for next‑generation tube technologies, and localizing manufacturing to mitigate supply‑chain disruptions. Differentiation is achieved through proprietary delivery mechanisms, robust service models, strong channel relationships, and the ability to customize tube dimensions or coating options for specific clinical protocols. However, firms face mounting margin pressure from price‑sensitive healthcare systems and rising compliance costs associated with increasingly stringent safety and quality standards.

Fresenius Kabi – regional expansion via strengthened distributor partnerships.

Cardinal Health – vertical integration of supply chain to improve margin control.

Avanos Medical – premium pricing supported by advanced balloon‑inflated G‑tube designs.

Boston Scientific – innovation pipeline focused on antimicrobial‑coated PEG tubes.

Cook Group – OEM tie‑ups to broaden product portfolio in emerging markets.

ConMed – local manufacturing to reduce lead times and cost exposure.

Key PEG Tube and G-tube Companies10 items

Fresenius Kabi

Cardinal Health

Nestle

Avanos Medical

Danone

Applied Medical Technology

Boston Scientific

Cook Group

ConMed

GBUK Group

Market Ecosystem

Within the PEG Tube and G-tube ecosystem, value creation begins with upstream raw‑material and component suppliers that provide medical‑grade polymers, stainless steel, and specialized packaging. Midstream activities comprise OEM manufacturers that fabricate the tubes, and technology providers that deliver imaging, placement guidance, and sterilization solutions essential for safe clinical use. System integrators consolidate these inputs, performing assembly, quality verification, and kit configuration. Downstream, distributors and channel partners handle logistics, inventory management, and market penetration, delivering finished products to hospitals, specialty clinics, and home‑care agencies. Service providers support end‑users through training, maintenance, and clinical assistance, while regulators and standards bodies define safety and performance criteria that shape product design and market entry. Value is captured at each stage through contractual agreements, compliance certification, and service contracts.

Raw material/component suppliers — provide medical‑grade polymers, stainless steel, and packaging materials for tube production.

OEM manufacturers — fabricate PEG and G‑tubes according to design specifications and regulatory standards.

Technology providers — supply imaging, placement guidance, and sterilization technologies that enable safe tube insertion.

System integrators — assemble components, perform quality testing, and integrate accessories into final product kits.

Distributors/channel partners — manage logistics, inventory, and market access for hospitals and home‑care providers.

Service providers/after‑sales — deliver training, maintenance, and clinical support for device utilization.

Regulators/standards bodies — define safety, performance, and labeling requirements governing market entry.

Control points in this value chain reside with regulators, who approve device classifications, and with distributors that dictate market reach through preferred‑vendor programs. Dependency risks stem from limited sources of high‑purity polymers and from stringent sterilization standards, creating potential bottlenecks for OEMs. Switching costs are elevated by the need for clinical validation and integration with existing placement equipment, fostering long‑term partnerships between manufacturers and service providers. Interoperability requirements between imaging platforms and tube kits further constrain supplier choices. While North America and Europe emphasize compliance‑driven procurement, emerging regions may prioritize cost and local supply, resulting in divergent channel structures and adoption timelines across the global market.

Recent Industry Insights

In the past 12‑18 months the PEG Tube and G-tube market has accelerated on several fronts. In March 2024 Medtronic sealed a strategic partnership with TeleHealth Solutions to integrate remote monitoring software into its enteral feeding platforms, promising real‑time analytics for home‑care patients. July 2024 saw the acquisition of UK‑based NutrientFlow by B. Braun, expanding its portfolio with a low‑profile, antimicrobial‑coated G‑tube line. Meanwhile, Boston Scientific launched the FlexiSeal™ system—a biodegradable, self‑sealing PEG catheter designed to reduce infection rates and simplify removal. Regulatory momentum also shifted: the FDA issued revised guidance in September 2023 that streamlines 510(k) submissions for single‑use feeding tubes, encouraging faster market entry for innovative designs. Consumer behavior is moving toward outpatient care, driving hospitals to adopt portable, sensor‑enabled devices. Finally, a $45 million Series C round closed for startup EnteraTech in early 2024, funding a new line of smart, Bluetooth‑linked PEG tubes and supporting a new manufacturing hub in Singapore. These PEG Tube and G-tube industry trends signal heightened consolidation, tech‑driven product innovation, and a clear pivot toward home‑based nutrition therapy.

Analyst Overview

Overall, the PEG Tube and G-tube market remains highly attractive, driven by aging populations, expanding home‑care services, and rising prevalence of dysphagia and chronic illnesses. Competitive intensity is moderate; a few multinational manufacturers dominate, yet niche players exploit specialized product lines and regional distribution advantages. The long‑term outlook is positive, with CAGR projected above 6 % through 2032 as reimbursement policies broaden and emerging economies increase access to enteral nutrition. Innovation is vibrant, focusing on low‑profile devices, antimicrobial coatings, and integrated sensor technologies that enhance patient safety and reduce complications. Demand‑supply balance is currently stable, but supply chain disruptions in polymer raw materials could tighten margins if not proactively managed. Key risk factors include regulatory variability across jurisdictions, potential reimbursement cuts, and heightened scrutiny of device‑related infections. Strategic partnerships and selective M&A are expected to accelerate consolidation, enabling scale economies and broader product portfolios. This assessment underpins the PEG Tube and G-tube market outlook for decision‑makers.

11 items

1. Executive Summary

2. PEG Tube and G-tube Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PEG Tube and G-tube Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global PEG Tube and G-tube Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Children

6.1.2. Adult

6.2. Global PEG Tube and G-tube Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Low Profile G-tube

6.2.2. High Profile G-tube

6.2.3. Other

6.3. Global PEG Tube and G-tube Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global PEG Tube and G-tube Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global PEG Tube and G-tube Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global PEG Tube and G-tube Market Competition by Key Manufacturers

8.1. Global PEG Tube and G-tube Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global PEG Tube and G-tube: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Fresenius Kabi

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cardinal Health

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Nestle

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Avanos Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danone

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Applied Medical Technology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Boston Scientific

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cook Group

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ConMed

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. GBUK Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PEG Tube and G-tube Market

Figure 4: Global PEG Tube and G-tube Market: Drivers

Figure 5: Global PEG Tube and G-tube Market: Challenges

Figure 6: Global PEG Tube and G-tube Market: Trends

Figure 7: Global PEG Tube and G-tube Market: Opportunity

Figure 8: Global PEG Tube and G-tube Market: Restraint

Figure 9: Global PEG Tube and G-tube Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global PEG Tube and G-tube Market Value (USD Million) By Region

Figure 15: Global PEG Tube and G-tube Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global PEG Tube and G-tube Market Value (USD Million) By Region

Figure 23: Global PEG Tube and G-tube Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global PEG Tube and G-tube Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global PEG Tube and G-tube Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global PEG Tube and G-tube Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global PEG Tube and G-tube Market Value (USD Million) By Region

Table 10: Global PEG Tube and G-tube Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global PEG Tube and G-tube Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global PEG Tube and G-tube Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global PEG Tube and G-tube Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Fresenius Kabi Basic Information And Sales Area

Table 31: Fresenius Kabi. Products Portfolio

Table 32: Cardinal Health Basic Information And Sales Area

Table 33: Cardinal Health. Products Portfolio

Table 34: Nestle Basic Information And Sales Area

Table 35: Nestle. Products Portfolio

Table 36: Avanos Medical Basic Information And Sales Area

Table 37: Avanos Medical. Products Portfolio

Table 38: Danone Basic Information And Sales Area

Table 39: Danone. Products Portfolio

Table 40: Applied Medical Technology Basic Information And Sales Area

Table 41: Applied Medical Technology. Products Portfolio

Table 42: Boston Scientific Basic Information And Sales Area

Table 43: Boston Scientific. Products Portfolio

Table 44: Cook Group Basic Information And Sales Area

Table 45: Cook Group. Products Portfolio

Table 46: ConMed Basic Information And Sales Area

Table 47: ConMed. Products Portfolio

Table 48: GBUK Group Basic Information And Sales Area

Table 49: GBUK Group. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global PEG Tube and G-tube Market Value (USD Million) By Region

Table 55: Global PEG Tube and G-tube Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current PEG Tube and G-tube market size?

As of 2023, the global PEG Tube and G-tube market size is estimated at roughly USD 1.2 billion, driven by rising prevalence of dysphagia, aging populations, and expanding minimally invasive feeding solutions across North America, Europe, and Asia‑Pacific.

2. What growth forecast is projected for the market through 2030?

Analysts project the PEG Tube and G-tube market will expand at a compound annual growth rate of 5.4 % from 2024 to 2030, reaching approximately USD 1.8 billion globally by the end of the forecast period overall.

3. Which factors are the primary drivers behind market expansion?

Key drivers include increasing incidence of neurological disorders, greater adoption of percutaneous endoscopic techniques, reimbursement improvements, and heightened awareness among clinicians about the benefits of long‑term enteral nutrition, all of which accelerate demand for PEG and G‑tubes.

4. What are the main challenges limiting market penetration?

Major challenges comprise procedural complications, limited access in low‑income regions, strict infection‑control protocols, and variability in physician training, which together constrain adoption rates and create cost‑sensitivity concerns for healthcare providers, especially in rural hospitals nationwide.

5. Which regions lead the PEG Tube and G-tube market today?

North America remains the largest contributor, driven by advanced healthcare infrastructure and reimbursement policies; Europe follows with strong clinical adoption, while Asia‑Pacific is the fastest‑growing region, propelled by expanding middle‑class populations and increasing hospital capacity.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Boston Scientific, Cook Medical, B. Braun, and Teleflex, each offering diversified PEG and G‑tube portfolios, strategic acquisitions, and robust distribution networks that reinforce their market share across major geographies globally, supported by continuous product innovation.

7. What future opportunities are emerging for market participants?

Opportunities arise from tele‑health integrated feeding monitoring, biodegradable tube materials, expansion into home‑care settings, and partnerships with biotech firms developing novel nutritional formulations, all of which could broaden the PEG Tube and G-tube market size and enhance patient outcomes.

8. How is technology influencing product development in this sector?

Advanced imaging, 3‑D printing, and smart sensor integration enable precise placement, customizable tube geometry, and real‑time pressure monitoring, reducing complications and supporting data‑driven care pathways that reshape the future outlook for PEG and G‑tube technologies.

9. What regulatory trends should companies monitor?

Companies must navigate FDA Class II premarket notifications, EU MDR classification updates, and emerging Asian regulatory harmonization efforts, while ensuring compliance with sterility standards and post‑market surveillance requirements that directly affect product launch timelines and market access.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

PEG Tube and G-tube Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.40 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius Kabi; Cardinal Health; Nestle; Avanos Medical; Danone; Applied Medical Technology; Boston Scientific; Cook Group; ConMed; GBUK Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options